Skip to main content

Table 7 Correlation between ribavirin dose reduction or discontinuation and relapse/non-response to treatment

From: Study the response of Qurevo (ombitasvir, paritaprevir, and ritonavir) in end-stage renal disease patients with hepatitis C virus

Relapses and non-response to treatment

Ribavirin reduction or discontinuation

Chi-square

Yes

No

Total

N

%

N

%

N

%

X2

P-value

No relapse, no non-response

4

100.00

42

91.30

46

92.00

0.378

0.828

Relapse

0

0.00

2

4.35

2

4.00

Non-response to ttt

0

0.00

2

4.35

2

4.00

Total

4

100.00

46

100.00

50

100.00